IRIS
CARAMORI, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.486
AS - Asia 6.095
EU - Europa 3.564
SA - Sud America 3.535
AF - Africa 176
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.869
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.326
BR - Brasile 3.041
SG - Singapore 2.350
CN - Cina 1.689
IE - Irlanda 1.423
HK - Hong Kong 826
VN - Vietnam 631
SE - Svezia 592
IT - Italia 576
RU - Federazione Russa 327
AR - Argentina 189
DE - Germania 158
PL - Polonia 110
EC - Ecuador 88
IN - India 83
BD - Bangladesh 70
ID - Indonesia 69
MX - Messico 66
GB - Regno Unito 65
CO - Colombia 64
TR - Turchia 63
FI - Finlandia 62
ZA - Sudafrica 54
FR - Francia 51
IQ - Iraq 46
VE - Venezuela 45
UA - Ucraina 43
CA - Canada 42
PY - Paraguay 40
MA - Marocco 31
PK - Pakistan 30
UZ - Uzbekistan 28
AT - Austria 26
BE - Belgio 25
CL - Cile 24
TN - Tunisia 22
JP - Giappone 21
KZ - Kazakistan 18
PE - Perù 18
JO - Giordania 17
AZ - Azerbaigian 16
NL - Olanda 16
UY - Uruguay 16
KE - Kenya 15
EG - Egitto 14
AE - Emirati Arabi Uniti 12
IL - Israele 12
CZ - Repubblica Ceca 11
ES - Italia 11
NP - Nepal 11
OM - Oman 11
PA - Panama 11
BO - Bolivia 10
SN - Senegal 10
BG - Bulgaria 9
HN - Honduras 9
LT - Lituania 9
AL - Albania 8
CI - Costa d'Avorio 8
DO - Repubblica Dominicana 8
GE - Georgia 8
GR - Grecia 8
KG - Kirghizistan 8
LK - Sri Lanka 8
TW - Taiwan 8
AU - Australia 7
AM - Armenia 6
AO - Angola 6
BH - Bahrain 6
CH - Svizzera 6
IR - Iran 6
JM - Giamaica 6
CR - Costa Rica 5
DZ - Algeria 5
KR - Corea 5
MY - Malesia 5
PS - Palestinian Territory 5
SY - Repubblica araba siriana 5
GT - Guatemala 4
LB - Libano 4
PH - Filippine 4
RO - Romania 4
RS - Serbia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
CG - Congo 3
EE - Estonia 3
ET - Etiopia 3
LV - Lettonia 3
MK - Macedonia 3
NI - Nicaragua 3
TH - Thailandia 3
GA - Gabon 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
SA - Arabia Saudita 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
Totale 19.854
Salva come PNG Salva come JPEG
Città #
Dublin 1.423
Singapore 881
Hong Kong 823
Dallas 799
Ashburn 789
Beijing 649
Chandler 541
Dearborn 509
Nyköping 399
Princeton 327
The Dalles 322
Jacksonville 268
São Paulo 248
Ho Chi Minh City 247
Des Moines 232
San Mateo 224
Cambridge 219
Messina 189
Los Angeles 183
Moscow 180
Medford 168
Redondo Beach 129
Hanoi 125
Jinan 116
Shenyang 110
Warsaw 106
Buffalo 105
Rio de Janeiro 91
Tianjin 84
Belo Horizonte 73
Munich 61
Nanjing 61
Curitiba 59
Wilmington 59
Ningbo 58
Zhengzhou 54
Ann Arbor 48
Hebei 47
Bremen 46
New York 46
Brasília 44
Haikou 39
Porto Alegre 39
Lanzhou 38
Nanchang 38
Campinas 37
Pune 37
Salvador 34
Turku 34
Naples 33
Rome 32
Haiphong 31
Hangzhou 31
Quito 29
Taizhou 28
Tashkent 28
Ribeirão Preto 26
Guarulhos 25
Brooklyn 24
Santo André 24
Brussels 23
Guayaquil 23
Jakarta 22
Asunción 21
Da Nang 21
Milan 21
Baghdad 20
Bogotá 20
Fortaleza 20
Fuzhou 20
Guangzhou 20
Thái Bình 20
Caxias do Sul 19
Goiânia 19
Maceió 19
Tokyo 19
Johannesburg 18
Sorocaba 18
Betim 17
Buenos Aires 17
Istanbul 17
Jiaxing 17
Recife 17
Cape Town 16
Changsha 16
São Bernardo do Campo 16
Baku 15
Chennai 15
Contagem 15
London 15
Montevideo 15
Stockholm 15
Cassino 14
Colombo 14
Dong Ket 14
Frankfurt am Main 14
Joinville 14
Nairobi 14
Nuremberg 14
Osasco 14
Totale 12.447
Salva come PNG Salva come JPEG
Nome #
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. 210
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. Basi fisiologiche. I parte. 208
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 190
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 132
Hereditary hyperhomocysteinemia associated with nephrotic syndrome complicated by artery thrombosis and chronic thromboembolic pulmonary hypertension: A case report 132
An unusual cause of chest pain 130
AN UNUSUAL CASE OF CHRONIC AIRFLOW OBSTRUCTION IN A HEAVY SMOKER 128
Molecular links between COPD and lung cancer: new targets for drug discovery? 127
An unusual cause of dyspnoea in a patient with chronic ischemic heart disease 118
A case of fibrosing interstitial pneumonia 116
Autoimmunity and COPD: Clinical Implications 112
Role of Stem Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema 112
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 112
Polmonite interstiziale fibrosante da amiodarone 110
Trattamento personalizzato dei pazienti con BPCO in fase stabile [Personalised treatment of stable COPD patients] 108
[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.] 106
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines 106
Role of Atypical Chemokines and Chemokine Receptors Pathways In the Pathogenesis of COPD 105
Role of the mucins in pathogenesis of COPD: implications for therapy 102
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis 101
Posttranscriptional Gene Regulatory Networks in Chronic Airway Inflammatory Diseases: In silico Mapping of RNA-Binding Protein Expression in Airway Epithelium 99
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 98
Bacterial infections in the lungs of patients with systemic autoimmune diseases 98
Immunomodulatory effect of gefitinib in epidermal growth factor receptor tyrosine kinase inhibitors sensitive and resistant Non small cell lung cancer: role of the RNA binding protein HuR 98
2 agonisti inalatori nel trattamento dell’asma bronchiale e delle broncopneumopatie croniche ostruttive. 97
Anatomia e fisiologia clinica della pleura. 95
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 92
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 92
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT 91
Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. 89
Asthma under/misdiagnosis in primary care setting: An observational community-based study in Italy 89
Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients 89
New drugs under development for COPD 88
Allergen Responses Modified by a GATA3 DNAzyme 87
Functional role of inflammasome activation in a subset of obese nonsmoking patients with severe asthma 87
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 86
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients 85
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. 84
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive.Basi fisiologiche. II parte. 83
Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD 82
Commentary on "Major Complications Associated with Conventional Transbronchial Needle Aspiration" 82
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes. 81
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 81
Transcription inhibitors and inflammatory cell activity 81
Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease 81
Activation of NF-kappaB transcription factor in asthma death 80
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 80
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine 79
Epithelial Posttranscriptional Gene Regulatory Networks In Chronic Airway Inflammation: In Silico Mapping Of RNA-Binding Protein Expression 77
D-dimer value in the diagnosis of pulmonary embolism — May it exclude only? 77
OXIDANTS AND ANTIOXIDANTS | Antioxidants, Nonenzymatic 77
Controllo della broncopneumopatia cronica ostruttiva in Italia 77
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance 76
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 76
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease. 74
Airway obstruction in chronic obstructive pulmonary disease. 74
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype? 74
Asthma death. 73
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 72
Gender differences in COPD management in a Sicilian general practice setting: a cohort study evaluating the impact of educational interventions 72
Attuali progressi nel trattamento dell’asma bronchiale nell’adulto. 71
Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study 71
Treatable traits in COPD patients 70
Corticosteroid resistance in asthma: Cellular and molecular mechanisms 70
Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study. 69
Asma. 69
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 69
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 69
Asma. 69
Malattie virali dell’apparato respiratorio 68
Interferonopathy: A potential link between innate immunity and autoimmunity in the pathogenesis of COPD 68
Transcription factors in asthma and COPD 66
Kinase targets and inhibitors for the treatment of airway inflammatory diseases: the next Generation of drugs for severe asthma and COPD?. 66
TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase 65
Rischio di polmonite durante trattamenti regolari a lungo termine con glucocorticoidi inalatori nei pazienti con BPCO stabile: Revisione sistematica della letteratura 65
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 65
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 65
Asthma: a chronic infectious disease? 65
A link between lung injury and inflammatory myopathies: making the diagnosis 65
Chronic obstructive pulmonary disease and lung cancer: new molecular insights 65
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 65
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 64
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 64
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio. 64
Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study 64
COPD exacerbations: definitions and classifications 64
Therapies acting on transcription: overview. 64
The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide 64
Birbeck granules: contribution to the comprehension of intracytoplasmic evolution. 64
Anti-inflammatory treatments for asthma: past, present, future. 63
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 63
Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease. 63
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 63
Quality of life in asthma and COPD: is it measurable in primary care? 63
Donna non fumatrice con asma bronchiale difficile da controllare. 63
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy. 63
Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease 63
Studio clinico-epidemiologico sulle neoplasie polmonari maligne. Confronto tra 2 coorti di pazienti nei quinquenni 1981-5 e 1991-5. 63
Sport e inquinamento atmosferico 63
Regulation of Wnt4 in chronic obstructive pulmonary disease 63
Totale 8.538
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.389
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021325 0 0 0 0 0 8 14 91 83 59 44 26
2021/20221.672 5 65 5 273 27 13 181 87 21 73 336 586
2022/20232.907 368 189 104 152 134 184 35 96 1.557 8 52 28
2023/2024871 53 81 54 86 71 170 24 31 5 27 11 258
2024/20256.107 74 28 80 314 210 56 91 1.421 1.606 358 711 1.158
2025/20265.959 547 1.071 1.456 1.823 974 88 0 0 0 0 0 0
Totale 20.399